RASAL1 and breast cancer: The 22 patients carrying ROS1 variants had a mean age at BC diagnosis of 41.36 years, while the 5 patients with RASAL1 variants had been diagnosed with BC at 36.2 years of age on average, compared to 38.29 years of patients with no variant detected in ROS1/RASAL1.